Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs. - Wikidata - awgldk - TriplyDB

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

http://www.wikidata.org/entity/Q37981634

about

Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders.Nanotechnology for CNS delivery of bio-therapeutic agents.The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity.Multifunctional adamantane derivatives as new scaffolds for the multipresentation of bioactive peptides.Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond.Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.Preparation and complete (1) H and (13)C assignment of some pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane-8,11-dione (PCUD) derivatives.Synthesis and NMR elucidation of pentacycloundecane-derived hydroxy acid peptides as potential anti-HIV-1 agents

P2860

Q38066606-FD3B3501-B268-48B4-BCD7-31817BF69218 Q38124859-FAF28B92-6658-4D99-BD12-2870B0EBC8DD Q38201104-3B881D8C-C1BA-4B6B-BCBE-A2E53196C858 Q38275427-9498633D-44CA-4602-B32F-6C97C7DF1EB8 Q38447289-6FA0BB17-C8DD-4A5D-96C9-FB0BC8A30405 Q41059066-2814090C-FC92-4A34-BECA-E1E6CA1F74E8 Q50489647-0696420F-7B97-4615-B03D-FC2C335179A1 Q58035067-05D6EC4B-8BD6-489B-A445-AFB48ABFF07D

P2860

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

http://www.wikidata.org/entity/Q37981634

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@en

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@nl

type

label

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@en

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@nl

prefLabel

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@en

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@nl

P1433

Q37981634-A75F4733-8D5B-4192-93A8-EF1992B7E616

P1476

Q37981634-6EA05926-183D-4DBC-899E-84E7143F937F

P2093

Q37981634-018ECD79-4A7E-4EF1-BAC3-A6CB11C2E885

Q37981634-2F507004-EB4B-469F-8DB2-885C0E1B42DB

Q37981634-538821B8-E56C-4F21-9C49-B4FA6B64A5A1

Q37981634-5607035B-3C94-4247-9C02-76DD73A5D767

Q37981634-8CF5B77E-5296-4B39-AF5F-0C97BEB53540

Q37981634-C75B4FA1-FA19-4386-B136-41F7F852BDC4

Q37981634-E7A34E0A-30B3-4778-AA62-97CF3BE10266

P2860

Q37981634-0263FB10-0C8A-49E8-8CC2-506C30F86C66

Q37981634-03A6F64A-10A9-4443-BEF6-1BFAF53FC45E

Q37981634-0A4392E7-9909-4E50-B578-E24D5A55E269

Q37981634-0AC77C64-21A6-4E03-8EE4-36C04A2ACD6F

Q37981634-0ACAFB72-7CC7-408E-ABAA-2584C1483E54

Q37981634-0EE3F81A-6B9F-45DD-82C6-F6C1A8E76684

Q37981634-105AF2D1-5CBC-459E-8FE3-91C6942B0B3B

Q37981634-10B409CF-3E8D-43F0-9E75-1310A1E48E67

Q37981634-11C5E809-2527-4AF8-835A-9513FF25C3B4

Q37981634-14FD0A33-89FE-490C-AF46-D25826AE6A89

P304

Q37981634-6A16B1CF-99F3-45EE-839A-0E029FCC1C7F

P31

Q37981634-214C0F55-3343-49DC-B23B-F2D5ED25E058

P356

Q37981634-3E2112A9-C211-4E5D-9CB0-8F699AB3E3E3

P433

Q37981634-917F8C68-4C20-40B5-AD84-AAC6C1E25855

P478

Q37981634-B2562610-056E-48C8-A3FC-50A5BE7E0A6F

P577

Q37981634-41759181-3EFC-4597-88DC-142C78528D8C

P698

Q37981634-5D09AF00-F20E-4060-9D5A-C42527730F10

P356

P1433

P1476

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

@en

P2093

Cornelis J Van der Schyf

http://www.w3.org/2001/XMLSchema#string

Douglas W Oliver

http://www.w3.org/2001/XMLSchema#string

Hendrik Gert Kruger

http://www.w3.org/2001/XMLSchema#string

Jacques Joubert

http://www.w3.org/2001/XMLSchema#string

Sarel F Malan

http://www.w3.org/2001/XMLSchema#string

Thavendran Govender

http://www.w3.org/2001/XMLSchema#string

Werner J Geldenhuys

http://www.w3.org/2001/XMLSchema#string

P2860

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

Sigma receptors: potential targets for a new class of antidepressant drug

Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release

Sigma receptors: potential medications development target for anti-cocaine agents

Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies

Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice

Structure and function of the blood-brain barrier

Mechanisms underlying inflammation in neurodegeneration

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration.

Blood-brain barrier delivery.

P304

375-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201100559

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22307951

http://www.w3.org/2001/XMLSchema#string